Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62056069 | chr16:89912000 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056070 | chr16:89913164 | C/T | 0.000206 | 170 | 25.87 | 24.1 | 36.37 | KM Plot |
PCPG | rs62056087 | chr16:89920383 | C/A | 0.000185 | 172 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056091 | chr16:89930414 | G/A | 0.000214 | 171 | 25.77 | 22.63 | 36.37 | KM Plot |
PCPG | rs62056096 | chr16:89933306 | C/T | 0.000214 | 171 | 25.77 | 22.63 | 36.37 | KM Plot |
PCPG | rs62056099 | chr16:89939327 | G/A | 0.000191 | 170 | 25.77 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056100 | chr16:89939753 | C/T | 0.000196 | 174 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs62056102 | chr16:89941438 | T/C | 0.000194 | 174 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62056103 | chr16:89942781 | G/A | 0.000211 | 173 | 25.77 | 20.2 | 36.37 | KM Plot |
PCPG | rs62056110 | chr16:89946388 | A/C | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs62056560 | chr16:90148930 | G/T | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs62070320 | chr16:89573689 | A/G | 0.000276 | 174 | 27.6 | 25.28 | 19.2 | KM Plot |
PCPG | rs62070324 | chr16:89583067 | G/A | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs62070325 | chr16:89583189 | C/T | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs62070326 | chr16:89583578 | G/A | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |